The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: doxorubicin hydrochloride     Quarter: 2016Q3

Total Records: 406     Number of Pages: 21

DRUGNAME PT EventCount
DOXORUBICIN HYDROCHLORIDE. Ejection fraction decreased 6
DOXORUBICIN HYDROCHLORIDE. Embolism 6
DOXORUBICIN HYDROCHLORIDE. Haemoglobin decreased 6
DOXORUBICIN HYDROCHLORIDE. Hypokalaemia 6
DOXORUBICIN HYDROCHLORIDE. Leukopenia 6
DOXORUBICIN HYDROCHLORIDE. Pulmonary embolism 6
DOXORUBICIN HYDROCHLORIDE. Toxicity to various agents 6
DOXORUBICIN HYDROCHLORIDE. White blood cell count decreased 6
DOXORUBICIN HYDROCHLORIDE. Chills 5
DOXORUBICIN HYDROCHLORIDE. Dehydration 5
DOXORUBICIN HYDROCHLORIDE. Pain 5
DOXORUBICIN HYDROCHLORIDE. Pulmonary oedema 5
DOXORUBICIN HYDROCHLORIDE. Thrombosis 5
DOXORUBICIN HYDROCHLORIDE. Urinary tract infection 5
DOXORUBICIN HYDROCHLORIDE. Acute respiratory distress syndrome 4
DOXORUBICIN HYDROCHLORIDE. Arrhythmia 4
DOXORUBICIN HYDROCHLORIDE. Asthenia 4
DOXORUBICIN HYDROCHLORIDE. Back pain 4
DOXORUBICIN HYDROCHLORIDE. Blood bilirubin increased 4
DOXORUBICIN HYDROCHLORIDE. Dyspnoea 4

Total Records: 406     Number of Pages: 21